PSA Values in Study Population Considering 68Ga-PSMA Ligand PET/CT Results, ADT, GS, and Type of RT
Category | PSA (ng/mL) | P |
Positive vs. negative PET/CT findings | 6.7 (range, 2.2–158.4; interquartile range, 4.4–10.4) (n = 107) vs. 3.8 (range, 2.8–11.1; interquartile range, 3.5–5.0) (n = 11) | 0.0152 |
ADT vs. without ADT | 7.7 (range, 2.2–65.0; interquartile range, 4.6–15.6) (n = 45) vs. 5.9 (range, 2.2–158.4; interquartile range, 3.9–8.9) (n = 73) | 0.087 |
GS ≤ 7 vs. ≥ 8 | 7.2 (range, 2.8–158.4; interquartile range, 5.1–11.0) (n = 61) vs. 5.0 (range, 2.2–25.0; interquartile range, 3.4–9.5) (n = 25) | 0.056 |
EBRT vs. Brachytherapy | 7.0 (range, 2.2–65.0; interquartile range, 4.0–11.0) (n = 77) vs. 5.7 (range, 2.6–158.4; interquartile range, 4.3–9.0) (n = 41) | 0.340 |
Data are median.